ZIMOXICLAV-625 is a combination antibiotic formulation containing Amoxicillin (500 mg), Clavulanic Acid (125 mg), and Lactic Acid Bacillus (60 million spores), designed to effectively treat a wide range of bacterial infections. Amoxicillin, a penicillin-type antibiotic, works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid helps prevent bacterial resistance, ensuring the effectiveness of the antibiotic. The inclusion of Lactic Acid Bacillus, a beneficial probiotic, helps maintain a healthy gut flora during antibiotic therapy, minimizing common digestive side effects like diarrhea. ZIMOXICLAV-625 is an ideal choice for treating respiratory, urinary tract, skin, and other bacterial infections.
Amoxicillin (500 mg): A broad-spectrum penicillin antibiotic that works by inhibiting the growth of bacteria. It disrupts the bacterial cell wall, leading to bacterial cell death and helping to resolve infections caused by susceptible organisms.
Clavulanic Acid (125 mg): A beta-lactamase inhibitor that prevents certain bacteria from becoming resistant to amoxicillin. This combination enhances the antibiotic’s effectiveness against a broader range of bacterial infections.
Lactic Acid Bacillus (60 million spores): A probiotic that supports the growth of beneficial gut bacteria, helping to prevent antibiotic-associated side effects such as diarrhea and maintaining a balanced gut microbiome during treatment.
Broad-Spectrum Antibiotic: ZIMOXICLAV-625 is effective against a wide range of bacterial infections, including respiratory infections (like bronchitis and pneumonia), urinary tract infections (UTIs), skin infections, and sinusitis.
Prevents Antibiotic Resistance: The addition of Clavulanic Acid ensures that ZIMOXICLAV-625 is effective against bacteria that may produce beta-lactamase, an enzyme that would normally deactivate amoxicillin.
Supports Digestive Health: The Lactic Acid Bacillus helps preserve gut health by restoring beneficial bacteria that may be disrupted during antibiotic therapy, reducing the risk of gastrointestinal issues like diarrhea.
Convenient Dosage: With a typical dosage of one tablet every 12 hours, ZIMOXICLAV-625 offers an easy and manageable treatment regimen.
Precautions:
Potential Side Effects:
Contraindications:
ZIMOXICLAV-625 by Medicox Life Science is an effective, well-rounded solution for bacterial infections, combining the proven power of Amoxicillin and Clavulanic Acid with the digestive benefits of Lactic Acid Bacillus. This combination not only treats infections but also helps preserve gut health during treatment, minimizing the common digestive disturbances associated with antibiotics. Whether you're dealing with respiratory, skin, or urinary infections, ZIMOXICLAV-625 provides broad-spectrum relief and ensures that you can recover with minimal side effects.
Our antibiotic range fights infections effectively, ensuring patients get the best chance for recovery. At Medicox Lifescience, we prioritize quality and efficacy, making our antibiotics a reliable choice for your Pharma Franchise needs.
Join as a partner, dealer, or distributor to deliver quality healthcare solutions across India.
Get in Touch